Key statistics
On Monday, Foghorn Therapeutics Inc (FHTX:NMQ) closed at 4.70, 59.60% above the 52 week low of 2.94 set on Apr 03, 2025.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 4.89 |
---|---|
High | 4.89 |
Low | 4.62 |
Bid | 4.50 |
Offer | 5.20 |
Previous close | 4.84 |
Average volume | 218.31k |
---|---|
Shares outstanding | 55.74m |
Free float | 45.04m |
P/E (TTM) | -- |
Market cap | 269.79m USD |
EPS (TTM) | -1.36 USD |
Data delayed at least 15 minutes, as of Jun 30 2025 21:00 BST.
More ▼
- Foghorn Therapeutics to Participate in Four Upcoming Investor Conferences
- Foghorn Therapeutics Provides First Quarter 2025 Financial and Corporate Update
- Foghorn Therapeutics to Participate in the Citizens Life Sciences Conference
- Foghorn Therapeutics Appoints Neil Gallagher and Stuart Duty to its Board of Directors
- Foghorn Therapeutics Presents New Preclinical Data on Selective SMARCA2 Inhibitor FHD-909 and Selective CBP and Selective EP300 Degrader Programs and Provides Pipeline Update
- Foghorn Therapeutics to Host Virtual Investor Event to Review Pipeline Updates in Conjunction with 2025 AACR Annual Meeting
- Foghorn Therapeutics Announces New Preclinical Data for Selective SMARCA2 Inhibitor FHD-909 and Selective CBP and EP300 Degrader Programs at 2025 AACR Meeting
- Foghorn Therapeutics Provides Financial Update for 2024 and 2025 Strategic Outlook
- Foghorn Therapeutics to Participate in Two Upcoming Investor Conferences
- Foghorn Therapeutics Highlights Program Progress and Strategic Objectives for 2025
More ▼